Samjin Pharm (005500) - Total Liabilities

Latest as of September 2025: ₩184.63 Billion KRW ≈ $125.12 Million USD

Based on the latest financial reports, Samjin Pharm (005500) has total liabilities worth ₩184.63 Billion KRW (≈ $125.12 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Samjin Pharm (005500) cash flow conversion to assess how effectively this company generates cash.

Samjin Pharm - Total Liabilities Trend (2013–2024)

This chart illustrates how Samjin Pharm's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Samjin Pharm to evaluate the company's liquid asset resilience ratio.

Samjin Pharm Competitors by Total Liabilities

The table below lists competitors of Samjin Pharm ranked by their total liabilities.

Company	Country	Total Liabilities
Habco Trans Maritima JK:HATM	Indonesia	Rp272.19 Billion
China ZhengTong Auto Services Holdings Limited F:ZA0	Germany	€25.47 Billion
Paragon Globe Bhd KLSE:3611	Malaysia	RM384.82 Million
BioInvent International AB ST:BINV	Sweden	Skr105.93 Million
MKH Oil Palm (East Kalimantan) Berhad KLSE:5319	Malaysia	RM66.39 Million
Train Alliance Sweden AB Series B ST:TRAIN-B	Sweden	Skr863.12 Million
Gobarto S.A. WAR:GOB	Poland	zł942.07 Million
Shieh Yih Machinery Industry Co Ltd TWO:4533	Taiwan	NT$3.95 Billion

Liability Composition Analysis (2013–2024)

This chart breaks down Samjin Pharm's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Samjin Pharm market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.25	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.70	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.41	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Samjin Pharm's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Samjin Pharm (2013–2024)

The table below shows the annual total liabilities of Samjin Pharm from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩163.51 Billion ≈ $110.81 Million	+5.81%
2023-12-31	₩154.54 Billion ≈ $104.73 Million	+18.24%
2022-12-31	₩130.69 Billion ≈ $88.57 Million	+32.92%
2021-12-31	₩98.33 Billion ≈ $66.64 Million	+76.92%
2020-12-31	₩55.58 Billion ≈ $37.66 Million	+19.07%
2019-12-31	₩46.68 Billion ≈ $31.63 Million	+3.84%
2018-12-31	₩44.95 Billion ≈ $30.46 Million	-7.09%
2017-12-31	₩48.38 Billion ≈ $32.79 Million	-16.41%
2016-12-31	₩57.88 Billion ≈ $39.22 Million	-20.36%
2015-12-31	₩72.67 Billion ≈ $49.25 Million	-12.72%
2014-12-31	₩83.26 Billion ≈ $56.43 Million	-8.46%
2013-12-31	₩90.96 Billion ≈ $61.64 Million	--

About Samjin Pharm

KO:005500 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$155.42 Million

₩229.34 Billion KRW

Market Cap Rank

#17507 Global

#820 in Korea

Share Price

₩18710.00

Change (1 day)

-1.47%

52-Week Range

₩17240.00 - ₩21100.00

All Time High

₩50479.08